Cyclochlorotine
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Category | Mycotoxins |
Catalog number | BBF-01108 |
CAS | 12663-46-6 |
Molecular Weight | 572.44 |
Molecular Formula | C24H31Cl2N5O7 |
Purity | ≥ 98% |
Online Inquiry
Description
It is produced by the strain of Penicillium islandicum. It can accelerate the degradation of glycogen and make the Liver glycogen particles disappear.
Specification
Synonyms | Chloropeptide; Cyclic(L-3-phenyl-beta-alanyl-L-seryl-(3S-cis)-3,4-dichloro-L-prolyl-L-alpha-aminobutyryl-L-seryl) |
IUPAC Name | (3S,7R,10S,13S,16R,17S,18R)-17,18-dichloro-13-ethyl-3,10-bis(hydroxymethyl)-7-phenyl-1,4,8,11,14-pentazabicyclo[14.3.0]nonadecane-2,5,9,12,15-pentone |
Canonical SMILES | CCC1C(=O)NC(C(=O)NC(CC(=O)NC(C(=O)N2CC(C(C2C(=O)N1)Cl)Cl)CO)C3=CC=CC=C3)CO |
InChI | InChI=1S/C24H31Cl2N5O7/c1-2-14-21(35)30-16(10-32)22(36)29-15(12-6-4-3-5-7-12)8-18(34)27-17(11-33)24(38)31-9-13(25)19(26)20(31)23(37)28-14/h3-7,13-17,19-20,32-33H,2,8-11H2,1H3,(H,27,34)(H,28,37)(H,29,36)(H,30,35)/t13-,14+,15-,16+,17+,19-,20+/m1/s1 |
InChI Key | PMBVHCCVEPYDSN-BADCMNFISA-N |
Source | Cyclochlorotine is a mycotoxin produced by the common food storage mould Penicillium islandicum. |
Properties
Appearance | Acicular Crystal |
Boiling Point | 249 °C (Predicted) |
Melting Point | 255 °C |
Density | 1.5344 g/cm3 (Predicted) |
Toxicity
Carcinogenicity | 3, not classifiable as to its carcinogenicity to humans. |
Mechanism Of Toxicity | Cyclochlorotine (CC) causes hepatic necrosis and has carcinogenic properties. The in vitro application of CC on myocytes induced disruption of myofibrils and large accumulations of actin, myosin, alpha-actinin, and vinculin at the cellular processes. This agent also induced the formation of islands of myosin and alpha-actinin aggregates. Actin filament bundles in fibroblasts were either unaffected or disrupted completely. CC damage was dose-dependently reversible. The degree of CC influence on myofibrillar and cytoskeletal proteins seems to be in the order of actin, myosin/a-actinin/vinculin, desmin and tubulin. This order is proportional to the proximity of proteins to actomyosin of myofibrils. CC, in some as yet unknown manner, appeares to dismantle previously assembled myofibrils and to form aggregates of myofibrillar and cytoskeletal proteins. The accumulation of myoproteins, particularly actin, at the cellular peripheries was characteristic of CC treatment, but its mechanism remains to be clarified. Two different responses of fibroblasts were noted after CC treatment, i.e., actin filament bundles were either unaffected or were disrupted completely to result in the formation of actin islands. Also, cell damage caused by CC treatment is reversible. |
Reference Reading
Spectrum
Predicted LC-MS/MS Spectrum - 10V, Positive
Experimental Conditions
Collision Energy: 10 eV
Instrument Type: QTOF (generic), spectrum predicted by CFM-ID
Mass Resolution: 0.0001 Da
1H NMR Spectrum
Experimental Conditions
Nucleus: 1H
Frequency: 100
Recommended Products
BBF-02576 | Pneumocandin B0 | Inquiry |
BBF-03819 | Spinosyn A | Inquiry |
BBF-00664 | Alternariol | Inquiry |
BBF-04009 | Nigericin sodium | Inquiry |
BBF-00586 | Brefeldin A | Inquiry |
BBF-01729 | Hygromycin B | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2